Ticagrelor(274693-27-5) (trade name Brilinta in the US, Brilique and Possia in the EU) is a platelet aggregation inhibitor produced by AstraZeneca. The drug was approved for use in the European Union by the European Commission on December 3, 2010. The drug was approved by the US Food and Drug Administration on July 20, 2011.

June 21, 2017

prudect name : Ticagrelor(274693-27-5) (trade name Brilinta in the US, Brilique and Possia in the EU) is a platelet aggregation inhibitor produced by AstraZeneca. The drug was approved for use in the European Union by the European Commission on December 3, 2010. The drug was approved by the US Food and Drug Administration on July 20, 2011.
Ticagrelor

Synonyms: CAS NO: 274693-27-5Molecular Formula: C₂₃H₂₈F₂N₆O₄SMolecular Weight: 522.57Purity: 98% minSolubility: In DMSOStorage: -20°C

web site: www.medchemexpress.com